• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪肝作为胰岛素抵抗的后果和原因:2 型糖尿病肝脏的教训。

Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.

机构信息

Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.

出版信息

Endocr J. 2012;59(9):745-63. doi: 10.1507/endocrj.ej12-0228. Epub 2012 Aug 12.

DOI:10.1507/endocrj.ej12-0228
PMID:22893453
Abstract

Obesity is less common in the Asian population, but Asian people may be susceptible to obesity-associated metabolic dysregulation. Accumulating evidence suggests that insulin resistance is closely associated with ectopic fat accumulation in the liver. Whether this correlation is due to a causal relationship between the conditions has long been the subject of debate. Insulin resistance and type 2 diabetes affects liver pathology, typically leading to nonalcoholic fatty liver disease (NAFLD) by dynamically altering the hepatic genes involved in glucose and lipid metabolism. Conversely, how overnutrition induces hepatic insulin resistance has been studied intensively, and has been shown to involve excessive energy flux into mitochondria, toxic lipids, reactive oxygen species, and hepatokines. In this review, we focus on NAFLD both as a consequence and as a cause of insulin resistance through lessons learned from the liver of patients with type 2 diabetes.

摘要

肥胖在亚洲人群中较少见,但亚洲人可能易患与肥胖相关的代谢失调。越来越多的证据表明,胰岛素抵抗与肝脏内异位脂肪积累密切相关。这种相关性是否是由于这两种情况之间存在因果关系,长期以来一直是争论的主题。胰岛素抵抗和 2 型糖尿病会影响肝脏病理,通常通过动态改变参与葡萄糖和脂质代谢的肝基因,导致非酒精性脂肪性肝病 (NAFLD)。相反,营养过剩如何诱导肝胰岛素抵抗已被深入研究,研究表明这涉及过多的能量流入线粒体、毒性脂质、活性氧和肝激素。在这篇综述中,我们通过从 2 型糖尿病患者的肝脏中吸取的经验教训,重点关注非酒精性脂肪性肝病既是胰岛素抵抗的结果,也是其原因。

相似文献

1
Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.脂肪肝作为胰岛素抵抗的后果和原因:2 型糖尿病肝脏的教训。
Endocr J. 2012;59(9):745-63. doi: 10.1507/endocrj.ej12-0228. Epub 2012 Aug 12.
2
Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.肝促生素在非酒精性脂肪性肝病糖尿病患者中的过表达可能会促进肝脏脂质蓄积增加。
Endocr Metab Immune Disord Drug Targets. 2019;19(2):185-188. doi: 10.2174/1871530318666180716100543.
3
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中胰岛素抵抗与氧化应激的相互依存关系。
Trends Mol Med. 2006 Dec;12(12):555-8. doi: 10.1016/j.molmed.2006.10.001. Epub 2006 Oct 17.
4
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?代谢综合征与非酒精性脂肪性肝病:胰岛素抵抗是其中的关联因素吗?
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. doi: 10.1016/j.mce.2015.02.018. Epub 2015 Feb 24.
5
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.人类糖尿病、肥胖症和非酒精性脂肪肝疾病的肝脏能量代谢。
Mol Cell Endocrinol. 2013 Oct 15;379(1-2):35-42. doi: 10.1016/j.mce.2013.06.002. Epub 2013 Jun 12.
6
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.肥胖和脂毒性在非酒精性脂肪性肝炎发展中的作用:病理生理学和临床意义。
Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8.
7
Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.非酒精性脂肪肝患者的肝线粒体功能适应在脂肪性肝炎中丧失。
Cell Metab. 2015 May 5;21(5):739-46. doi: 10.1016/j.cmet.2015.04.004.
8
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.2型糖尿病瘦患者和肥胖患者的异位脂肪与内脏脂肪沉积
J Am Coll Cardiol. 2016 Jul 5;68(1):53-63. doi: 10.1016/j.jacc.2016.03.597.
9
Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis.内质网-线粒体通讯障碍是肝胰岛素抵抗和脂肪变性的早期及因果触发因素。
J Hepatol. 2022 Sep;77(3):710-722. doi: 10.1016/j.jhep.2022.03.017. Epub 2022 Mar 28.
10
Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.肌肉减少性肥胖、胰岛素抵抗及其对心血管和代谢后果的影响。
Int J Mol Sci. 2020 Jan 13;21(2):494. doi: 10.3390/ijms21020494.

引用本文的文献

1
New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products.天然产物治疗代谢功能障碍相关脂肪性肝病的新方法。
ILIVER. 2024 Nov 8;3(4):100131. doi: 10.1016/j.iliver.2024.100131. eCollection 2024 Dec.
2
Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances.肝细胞癌:发病机制、分子机制及治疗进展
Front Oncol. 2025 Apr 8;15:1526206. doi: 10.3389/fonc.2025.1526206. eCollection 2025.
3
What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?
肌肉减少症与非酒精性脂肪性肝病有何关联?
Life (Basel). 2023 Dec 25;14(1):37. doi: 10.3390/life14010037.
4
Novel Curcumin Analogue L6H4 in Treating Liver Fibrosis and Type 2 Diabetes.新型姜黄素类似物L6H4治疗肝纤维化和2型糖尿病
Diabetes Metab Syndr Obes. 2023 Aug 30;16:2639-2650. doi: 10.2147/DMSO.S425038. eCollection 2023.
5
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.非酒精性脂肪性肝病(NAFLD)发病机制及天然产物的防治。
Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489.
6
Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis.握力与非酒精性脂肪性肝病之间的关联:一项系统评价和荟萃分析。
Front Med (Lausanne). 2022 Aug 26;9:988566. doi: 10.3389/fmed.2022.988566. eCollection 2022.
7
Whole-Body MRI-Derived Adipose Tissue Characterization and Relationship to Pulmonary Function Impairment.基于全身磁共振成像的脂肪组织特征及其与肺功能损害的关系。
Tomography. 2022 Feb 27;8(2):560-569. doi: 10.3390/tomography8020046.
8
The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?生酮饮食:对肌少症性肥胖有效吗?
Nutrients. 2022 Jan 30;14(3):620. doi: 10.3390/nu14030620.
9
An Overview of Alkylresorcinols Biological Properties and Effects.烷基间苯二酚的生物学特性与作用概述。
J Nutr Metab. 2022 Jan 5;2022:4667607. doi: 10.1155/2022/4667607. eCollection 2022.
10
A Novel Identified Peptide Hormone "Metabolitin" Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway.一种新发现的肽激素“代谢素”通过调节神经降压素和AMPK信号通路减轻非酒精性脂肪性肝病糖尿病小鼠小肠中的脂质吸收。
Evid Based Complement Alternat Med. 2021 Sep 28;2021:8386848. doi: 10.1155/2021/8386848. eCollection 2021.